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Hemorrhagic  fever  with  renal  syndrome  is  endemic  in  the  Balkans  with  epidemic  outbreaks  and  sporadic
cases  that  have  been  recorded  yearly  since  the  disease  was  ﬁrst  recognized.  The  incidence  of  Balkan
HFRS  is modest,  with  approximately  one  hundred  cases  reported  in most  years.  Seroepidemiological
investigations  conducted  in  several  Balkan  countries  revealed  an  overall  seroprevalence  of 6%  in Bosnia
and Herzegovina,  1.6%  in  Croatia,  4% in  Greece  and  1.7%  in  Slovenia,  respectively.  The complex  ecology
of  the  Balkan  Peninsula  supports  the  existence  of diverse  rodent  and  insectivore  species  which  harbor
several  pathogenic  and  non-pathogenic  hantaviruses.  Among  them  only  Dobrava (DOBV)  and  Puumala
(PUUV)  viruses  are  associated  with  disease  in  humans.  Comprehensive  clinical  studies  compared  clinical
signs  and  symptoms  between  patients  infected  with  either  virus.  A spectrum  of clinical  picture  of the
disease  ranges  from  mild  illness  typical  of PUUV  infections  to a  severe  form  with  fulminant  hemorrhagic
fever  and  an  overall  mortality  rate  of  9.8%  among  DOBV  infected  patients.  While severe  DOBV  cases  are
recognized  from  Slovenia  in  the North  to Greece  in the  South,  PUUV  infections  are  more  frequent  in
.  Balk
BV  an
 2014northern  part  of the  area
due to  co-existence  of  DO
©
. Historical perspectives
Hemorrhagic fever with renal syndrome is endemic in the
alkan Peninsula, and may  have existed there for decades. The ﬁrst
robable case of HFRS was reported in the former Yugoslavia in
952 as a case of acute renal failure successfully treated by per-
toneal dialysis (Simic, 1952). The patient was a soldier who was
nfected in the forest surrounding Fojnica in Bosnia and Herzego-
ina (B&H), where, in the later outbreaks, hundreds of HFRS cases
ave occurred. Then, in 1954, Radosˇevic´ and Mohacˇek described
our sporadic cases of HFRS in Croatia where one of the cases was
nfected during the season timberwork in the forest of Pohorje
n Slovenia. At the time, the authors were already aware of the
linical resemblance of the disease to that occurring in Scandi-
avia; therefore they named it Nephropathia Epidemica (Radosevic
nd Mohacek, 1954). Afterwards, clinical cases of HFRS were
lso reported from Albania (Eltari et al., 1987), Bulgaria (Verbev
nd Gabev, 1963), Greece (Antoniadis et al., 1984) and Romania
Manasia et al., 1977).
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Open access under CC BY-NC-ND ans  represent  an  area  with  a potential  need  for  hantavirus  vaccines,  but
d  PUUV  causing  HFRS  in the  same  region,  a universal  vaccine  is required.
 The  Authors.  Published  by Elsevier  B.V.  
Epidemic outbreaks as well as sporadic cases have been
recorded yearly, since the disease was  ﬁrst recognized in South-
East Europe. The ﬁrst documented epidemic of HFRS occurred
in a military camp in the forest of Frusˇka Gora in Serbia in 1961
(Heneberg et al., 1964). A second epidemic in 1967, affecting more
than 200 individuals with 5 fatalities, was centered in Bosnia and
Herzegovina (Fojnica and Focˇa) and in Croatia (Plitvice Lakes)
(Vesenjak-Hirjan et al., 1971). In summer of 1983 an outbreak
of HFRS occurred in the state of Epirus, north-western Greece. A
total of 8 patients were hospitalized during the outbreak; 3 were
severely ill and 1 died (Siamopoulos et al., 1985). A total of 276
persons with symptoms clinically compatible with a diagnosis
of HFRS were ofﬁcially reported in 1986 from all republics and
provinces of the former Yugoslavia with the highest incidence
in Montenegro (Avsˇicˇ-Zˇupanc et al., 1989; Gligic et al., 1989). A
nation-wide epidemic of HFRS occurred in all six republics and
two provinces of former Yugoslavia in 1989 when 226 HFRS cases
were serologically conﬁrmed. The severity of disease differed
from region to region, with an overall fatality of 6.6% (Gligic et al.,
1992). One of the largest outbreaks of HFRS took place in the
Balkan region during the war  in 1995 when clinical diagnosis was
serologically conﬁrmed in 128 patients, mainly soldiers, from the
Tuzla region in B&H (Hukic et al., 1996) and in 85 patients, mostly
soldiers (3 fatal), from several localities in Croatia (Kuzman et al.,
Open access under CC BY-NC-ND license.1997; Markotic´ et al., 1996, 2002b). The next epidemic year that
have affected Balkan countries was  in 2002 with >500 clinically
diagnosed patients mainly registered in Croatia, Slovenia and
B&H (Heyman et al., 2009; Hukic et al., 2010; Koren et al., 2008;
license.
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uzman et al., 2003). The same year an unusual outbreak of 11
FRS cases appeared among former injecting drug users in the
rug-treatable community Susret, Ivanovac, northeast of Croatia
Medved et al., 2002). In the following years of 2005 and 2008 an
ncreased hantavirus activity was noticed again in Slovenia, Croatia
nd B&H (Heyman et al., 2011; Kraigher et al., 2012). The largest
pidemic of HFRS so far occurred in 2012 in Slovenia and Croatia,
ith 188 and 184 laboratory conﬁrmed cases, respectively.
. Ecology
The ecology of hantaviruses in the Balkan Peninsula is com-
lex, given the existence of diverse rodent species, which reﬂects
he geographic location of the Balkan States at the meeting points
f Europe, Asia, and North Africa. By the detection of viral anti-
en, antibody, RNA ampliﬁcation or virus isolation the presence
f several pathogenic and non-pathogenic hantaviruses has been
emonstrated in the region. They are associated with four rodent
enera: Apodemus,  Myodes, Microtus, and Rattus;  and also with
nsectivore carriers. The most prominent hantavirus carrier in
he Balkans is the yellow necked mouse, A. ﬂavicollis, host of
obrava virus (DOBV), which is generally widespread through-
ut the region. These rodents prefer mature deciduous forests
ith areas where sufﬁcient plant diversity ensures an adequate
ood supply each year (Krysˇtufek, 1991; Vukic´evicˇ-Radic´ et al.,
006). Following a number of severe HFRS cases in the south-
astern part of Slovenia, DOBV was isolated in 1988, from the
ungs of the yellow necked mouse captured in Dobrava village.
n 1992, it was fully characterized and recognized as a unique
antavirus species (Avsˇicˇ-Zˇupanc et al., 1992). Subsequently, the
resence of DOBV in hosts and humans was reported from sev-
ral countries in South-East Europe: Albania, B&H, Bulgaria, Croatia,
reece, Romania, Serbia and Montenegro (reviewed in Heyman
t al., 2009). Another Apodemus host, A. agrarius or striped ﬁeld
ouse, is commonly found in grassy ﬁelds, cultivated areas and
oodlands of the Balkans (Krysˇtufek, 1991; Vukic´evicˇ-Radic´ et al.,
006) and it is a reservoir host for Saaremaa virus (SAAV) (Plyusnin
t al., 1997, 1999). Recently it was suggested to classify SAAV
rom outside Saaremaa island as Kurkino genetic lineage of DOBV.
OBV-Kurkino is responsible for a milder form of HFRS in Cen-
ral Europe (Klempa et al., 2013), but in the Balkan region the
irus was demonstrated only in rodents from Slovenia and Cro-
tia (Avsˇicˇ-Zˇupanc et al., 2000; Plyusnina et al., 2011). In south
alkan countries, like Greece, Romania, Albania, Macedonia, Serbia
nd Montenegro, almost all HFRS cases are cause by DOBV, but
o the north, more Puumala virus (PUUV) infections are observed.
or example in Slovenia and Croatia approximately 70% of HFRS
ases are caused by PUUV. The major carrier of PUUV is Myo-
es glareolus or bank vole, which inhabits mostly wet  coniferous
nd mixed forests to leafed forests, river banks and marshy areas
n the Balkans (Krysˇtufek, 1991). In concordance with numer-
us HFRS cases caused by PUUV in Slovenia, Croatia and B&H
igh antibody prevalence in bank voles was reported (Avsˇicˇ-
ˇupanc et al., 2007; Hukic et al., 2003; Tadin et al., 2012). The
revalence of hantavirus antibodies and antigens was detected
n average in 16% of A. ﬂavicollis, 8.1% A. agrarius and 16% of M.
lareolus, but a signiﬁcant difference was observed between epi-
emic and non-epidemic years. While during the non-epidemic
ears the prevalence of hantaviruses in hosts in endemic areas of
FRS in the former Yugoslavia was on average 9.2%, the preva-
ence of infection was on average 19.7% and 23% for the epidemic
ears 1986 and 1989, respectively (Avsˇicˇ-Zˇupanc et al., 1990,
993; Avsˇicˇ-Zˇupanc and Poljak, 1994; Gligic et al., 1992; Lukacˇ
t al., 1990). Despite some evidence of possible human infection
ith TULV in Central Europe (Vapalahti et al., 1996), currentlyearch 187 (2014) 27–33
no clinical case due to TULV infection has been reported in the
Balkan Peninsula. However, TULV RNA was ampliﬁed from tissue
samples of M.  arvalis,  M.  agrestis and M.  subterraneus (re-classiﬁed
from Pitymys subterraneus) in Slovenia, Croatia and Serbia (Korva
et al., 2009; Scharninghausen et al., 2002; Song et al., 2002). More-
over, as early as in 1989 there were reports of hantaviral antigens
discovered in tissues of Eurasian common shrews (Sorex araneus),
alpine shrews (Sorex alpinus), Eurasian water shrews (Neomys fodi-
ens) and common moles (Talpa europea) in areas of the former
Yugoslavia (Gligic et al., 1992). Later, in 2013 Seewis virus RNA was
ampliﬁed from tissues of S. araneus captured in Slovenia (Resman
et al., 2013).
3. Epidemiology
HFRS cases in the Balkan Peninsula are reported yearly, either as
sporadic cases or major outbreaks inﬂuenced by the abundance of
reservoir rodent populations (Table 1). The incidence of the disease
is modest, with approximately 100 cases per year (Heyman et al.,
2009), but, due to DOBV infection, the mortality can be high (on
average 12%) (Avsˇicˇ-Zˇupanc et al., 1999). Also, apparent seasonal
distribution, with most cases occurring in the summer months is
observed. Occupation is a dominant risk factor, with animal trap-
pers, forestry workers, farmers and military personnel at highest
risk (Heyman et al., 2009).
3.1. Albania and Macedonia
In Albania, the ﬁrst serologically conﬁrmed HFRS case dates to
1987, when a 27-year old man  presented with acute renal failure
and shock (Eltari et al., 1987). Also, in a HFRS epidemic, which
occurred in Yugoslavia in 1986, 4 out of 6 Albanian patients had
antibodies against hantaviruses (Gligic et al., 1989). In a study per-
formed between 2003 and 2006, 11.7% of the patients with clinical
suspicion of CCHF were actually conﬁrmed as HFRS cases, which
suggest that there are more unrecognized, severe HFRS cases in
Albania (Papa et al., 2008).
The ﬁrst report of a HFRS case in the Republic of Macedonia dates
to 1987. In a 3-year period, from 1987 to 1990, at least 10 DOBV
cases were diagnosed, with a 10% mortality rate (Polenakovic et al.,
1995).
3.2. Bosnia and Herzegovina
B&H has been recognized as a highly endemic region in the
Balkans for over 50 years. In addition to PUUV and DOBV, also
a Seoul virus was  also identiﬁed as a potential cause of HFRS in
B&H (Clement et al., 1994; Lundkvist et al., 1997; Markotic´ et al.,
1995). Infections caused by PUUV are more frequent (49.6%) than
infections caused by DOBV (26.1%) during both epidemic and non-
epidemic periods (Hukic et al., 2011). Since the ﬁrst documented
HFRS outbreak in 1967 more than 732 cases have been reported
(Heyman et al., 2011). Most HFRS cases have been observed as
large outbreaks, with signiﬁcant number of patients and mortality
varying from 4.86% in 1989 up to 7.3% in 1995 (Gligic et al., 1992;
Markotic´ et al., 1996). The seroprevalence in the general population
in B&H is 7.4% in the endemic region and 2.4% in the non-endemic
region (Hukic et al., 2010). Former soldiers, as an occupational risk
group, have signiﬁcantly higher seroprevalence (16.1%) compared
to the general population (6.2%) in the same area. In a comparison
of the seroprevalence of PUUV and DOBV among healthy individ-
ual in endemic regions it was  noted that antibodies against PUUV
are present in almost 6% of population, while DOBV seroprevalence
is only 1.5%. The difference is probably due to the fact that DOBV
causes a more severe form of HFRS and consequently less cases
remains undetected (Hukic et al., 2010).
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Table  1
HFRS cases in the Balkan countries registered during the period from 1952 to 2012.
Year/country Albaniaa and
Macedoniab
Bosnia and
Herzegovinac
Bulgariad Croatiae Greecef Serbiag and
Montenegroh
Sloveniai Romaniaj
1952–1960 – 1 97 3 – 1 1 27
1961  – – 8 – – 46 –
1962–1966 – – 53 – – – –
1967  – 160 33 14 – – –
1968–1982 – – 172 4 – 3 – –
1983  0 3 7 1 8 1 1 –
1984–1985 0 7 9 7 13 9 6 –
1986  1 15 20 4 – 163 2 –
1987–1988 2 10 – 6 – 13 18 –
1989  6 144 – 27 – 111 12 –
1990–1994 1 19 – 18 – 10 52 –
1995  – 354 – 85 – – 14 –
1996–2001 – – – 39 16 – 36 –
2002  – 136 – 401 8 128 33 –
2003–2004 – – – 16 6 65 21 –
2005  – 21 5 24 5 – 24 1
2006–2007 – 34 2 20 9 – 20 3
2008  – 25 4 19 1 – 46 4
2009–2011 – 27 7 21 7 – 36 13
2012  – 36 – 184 – – 188 –
Total  10 992 417 873 73 550 510 48
“–”, no data.
a Eltari et al. (1987) and Gligic et al. (1989).
b Polenakovic et al. (1995).
c Heyman et al. (2011), Heyman and Vaheri (2008), Hukic et al. (1996), Hukic et al. (2003) and Hukic et al. (2011).
d Chumakov et al. (1988), Verbev and Gabev (1963), Heyman et al. (2011) and Papa and Christova (2011).
e Cvetko et al. (2005), Markotic´ et al. (1996), Markotic´ et al. (2002b) and Medved et al. (2002).
f Antoniadis et al. (1987), Heyman et al. (2011), Heyman and Vaheri (2008) and Papa and Antoniadis (2001).
g Gligic et al. (1992) and Papa et al. (2006).
h Gledovic et al. (2008), Gligic et al. (1992) and Papa et al. (2006).
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.3. Bulgaria
HFRS has been a notiﬁable disease in Bulgaria since 1953 and
uring the period 1954–1986, 399 cases of HFRS were registered,
ith a 15.8% mortality rate. Serological investigation has conﬁrmed
OBV infection in 90.6% of investigated cases (Chumakov et al.,
988). In the last decade 36 cases have been reported mainly
n the southwestern region, in the areas of the Balkan and Rila-
irin-Rodopa mountain range. Genetic studies have revealed, that
ulgarian DOBV sequences cluster together with sequences from
eighboring Greece (Papa and Christova, 2011). Additionally, even
n non-endemic regions of the country approximately 2.8% of
atients with acute undifferentiated febrile illness are due to han-
avirus infections (Christova et al., 2013).
.4. Croatia
Croatia is an important natural focus for hantaviruses, where
he whole country, with the exception of the coastal region and
he islands, is endemic for HFRS, either caused by DOBV or PUUV
Markotic´ et al., 1996). Besides DOBV and PUUV also DOBV-Kurkino
enome sequences were found in rodents (A. agrarius) in Croatia
Plyusnina et al., 2011), but so far no documented HFRS case has
een associated with this virus in the region. Since the ﬁrst recogni-
ion of HFRS patients in 1952 (Radosevic and Mohacek, 1954) HFRS
as been regularly occurring in the country, mostly are sporadic
ases, with few epidemic outbreaks (Cvetko et al., 2005; Markotic´
t al., 1996, 2002b; Medved et al., 2002). From 10 to 20 sporadic
FRS cases are reported annually, with two-thirds of the patients
nfected with PUUV and only one-third with DOBV (Markotic´ et al.,
002b). A higher proportion of DOBV infections were found in the
inara mountain, region that was ﬁrst recognized in the outbreakt al. (2008) and Kraigher et al. (2012).
 al. (1977).
in 1995 (Kuzman et al., 1997). During the 2002 epidemic, when
401 cases were reported from all over the country, the majority of
the disease was recognized in the general population, with only a
small number of cases from risk groups (14.9%). Serological analysis
revealed DOBV antibodies in only 17 HFRS cases. The clinical man-
ifestations of the disease were observed as 65% mild and only 5%
severe, with 1 fatal case (Kuzman et al., 2003). A seroepidemiolog-
ical investigation among 300 forestry workers and 260 individuals
from the general population revealed that antibody prevalence
ranged from 0% to 8.9%, with an overall rate of 1.6% (Borcˇic´ et al.,
1991).
3.5. Greece
The study on HFRS in Greece started in 1980, where the ﬁrst
serological evidence of a HFRS case was presented in 1981 (Lee and
Antoniadis, 1981). Although, DOBV is a predominant cause of HFRS
cases in Greece, PUUV is also circulating in the country. Most human
infections are sporadic, with about ﬁve hospitalized cases annually.
From the description of the ﬁrst HFRS cases, and the start of rou-
tine diagnostics in 1997 up until 2001, 210 cases were reported
(Heyman and Vaheri, 2008; Papa and Antoniadis, 2001). The sever-
ity of the disease ranges from a mild or moderate form to severe and
fatal cases, but since most cases are caused by DOBV the average
mortality rate is high (9%) (Papa and Antoniadis, 2001). The most
endemic regions are in the northwest and northeast parts of the
country (Pindos and Rodopi mountain range), where 80% of total
HFRS cases occurs. No HFRS cases have so far been reported on the
islands (Papa and Antoniadis, 2001). Results of serological survey
demonstrated an overall seroprevalence of 4%, ranging from 0% up
to 14%, where higher percentage was  observed among individuals
with occupational risks (Antoniadis et al., 1987).
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.6. Serbia and Montenegro
Recognition of HFRS cases in Serbia dates from 1952 and since
hen most cases have been reported in large epidemics, with an
verage mortality rate of 10.5% (Gligic et al., 1992). Most DOBV
FRS cases were reported from the south of the country (Leskovac,
ranje, Nis, Surdulica, Vlasina), while PUUV cases are documented
n the north (Vojvodina and area near the Drina river). In a recent
hylogenetic analysis of DOBV gene sequence ampliﬁed from Ser-
ian patients, the sequences clustered together with strains from
lovenia, Slovakia and Greece. Serbian sequences differ by 0.3–2.6%
n the nucleotide level in the S segment and by 5.7% on the M seg-
ent in comparison with DOBV isolated in Slovenia (Papa et al.,
006).
In Montenegro the ﬁrst case was recognized in 1967 and since
hen 4 outbreaks were registered. During the period between 1995
nd 2005, 169 cases of HFRS were recognized. The incidence rate
as 2.6/100,000 inhabitants, with most cases observed in the rural
reas in the northeast of the country (Berane, Plav, Mojkovac,
luzine and Kolasin). Most HFRS cases (90%) were due to DOBV
nfection, with an average case fatality rate of 4.8%, ranging from
.1% to 15% (Gledovic et al., 2008).
.7. Slovenia
Slovenia is situated in the northern part of the Balkan Peninsula
nd several hantaviruses coexist in a single region of endemi-
ity. The presence of HFRS in Slovenia was ﬁrst reported in 1954
Radosevic and Mohacek, 1954). Soon after the introduction of
iagnostic capabilities for hantaviruses, the ﬁrst evidence of the
resence of two hantavirus responsible for human infections in
lovenia was reported (Avsˇicˇ-Zˇupanc et al., 1990). When DOBV
as isolated and characterized it became obvious that this virus
s responsible for a severe, even fatal form of HFRS (Avsˇicˇ-Zˇupanc
t al., 1992, 1994, 1999). In Slovenia, 511 clinically and laboratory
onﬁrmed cases of HFRS have occurred sporadically or in small epi-
emics, so far (Koren et al., 2008; Kraigher et al., 2012); out of them
34 were due to DOBV infection and 377 due to PUUV infection.
esides DOBV-Dobrava genotype also DOBV-Kurkino genotype was
iscovered in striped ﬁeld mice in Slovenia (Avsˇicˇ-Zˇupanc et al.,
000), but only recently a ﬁrst HFRS case, caused by DOBV-Kurkino
enotype, has been documented (Korva et al., 2013a, in press).
lthough HFRS patients have been found throughout the coun-
ry, most of them have been reported in the endemic regions of
jubljana and its surroundings, Dolenjska and Sˇtajerska. The clin-
cal severity of the disease caused by PUUV is signiﬁcantly lower
han that of HFRS due to DOBV. The overall mortality rate is 4.
%, but if only DOBV infections are considered, then the morality
ate is 9.8% (Avsˇicˇ-Zˇupanc et al., 1999; Kraigher et al., 2012). In the
eneral Slovenian population, the antibody prevalence against han-
aviruses is on average 1.7%, but it varied from 0% to 14.28% when a
roup of woodworkers was investigated (Avsˇicˇ-Zˇupanc and Poljak,
994).
.8. Romania
In Romania the ﬁrst HFRS cases were clinically diagnosed in
956 and until 1977, 27 recognized HFRS cases have been doc-
mented (Manasia et al., 1977). Up until 2008, when laboratory
iagnostic capabilities for hantaviruses was established in the
ational Reference Laboratory for Vector-Borne Infections, the
isease seems to have been completely overlooked in Romania. Ret-
ospectively, 5 HFRS cases were conﬁrmed in a series of patients
ith unconﬁrmed leptospirosis hospitalized from 2005 to 2007
Maftei et al., 2012). Since 2008, an additional 17 HFRS cases were
eported and all infections were conﬁrmed as DOBV. Althoughearch 187 (2014) 27–33
patients had a severe form of HFRS, in all the outcome of the dis-
ease was  favorable. Moreover, most HFRS cases were connected
with occupational hazards like shepherds or woodcutters (Heyman
et al., 2011; Maftei et al., 2012).
4. Clinical aspects
Two hantaviruses, PUUV and DOBV are responsible for clin-
ically manifested HFRS in patients in the Balkans (Avsˇicˇ-Zˇupanc
et al., 1999; Markotic´ et al., 1996, 2002b). There is only anecdotal
evidence of possible Seoul virus infection in B&H with a moder-
ate clinical picture and signiﬁcantly elevated liver transaminases.
However, at that time no molecular diagnostic tools were avail-
able in the region, so the infection was conﬁrmed only by ELISA
and cross reactivity to other hantaviruses was detected as well
(Markotic´ et al., 1995).
4.1. Similarities and differences between Puumala and Dobrava
virus infection
Unique situation, where both PUUV and DOBV are circulating in
a relatively small region, allowed for comparison of clinical signs
and symptoms between patients infected with either virus. Two
comprehensive studies were performed describing and comparing
characteristics of PUUV or DOBV infection in patients in Slovenia
and Croatia (Avsˇicˇ-Zˇupanc et al., 1999; Markotic´ et al., 2002b). In
general, DOBV infections caused a HFRS with moderate to severe
clinical picture, while PUUV infections resulted in mild to moder-
ate HFRS, although exceptions were noticed. Using our scale for
HFRS disease severity we showed that PUUV infections cause mild
clinical manifestations in 65% of patients, 24% patients had a mod-
erate clinical picture, while severe to very severe clinical pictures
were recorded in 8% and 3% patients, respectively. In patients with
DOBV infections, mild disease was  recorded in 44% and moderate in
almost the same percentage (40%) of patients, while 12% of patients
had severe and 4% very severe clinical pictures (Cebalo et al., 2003).
Also, a signiﬁcantly higher percentage of asymptomatic infections
in humans were caused by PUUV (69.8%) than by DOBV (17.5%)
(Hukic et al., 2011).
The most common ﬁndings were fever, chills, malaise, myalgia,
back and abdominal pain, headache, vomiting, diarrhea, blurred
vision, oliguria followed by polyuria (Avsˇicˇ-Zˇupanc et al., 1999;
Markotic´ et al., 2002b). Blurred vision, acute renal failure, diarrhea
and melena were signiﬁcantly more often registered in patients
with DOBV infection in Croatian patients (Markotic´ et al., 2002b).
However, in Slovenian patients, blurred vision was signiﬁcantly
more often recorded in patients with PUUV infection (Avsˇicˇ-Zˇupanc
et al., 1999). Most Croatian PUUV infected patients had elevated
systolic blood pressure on admission to the hospital while patients
infected with DOBV had normal blood pressure. Patients with DOBV
infection more often required hemodialysis, developed shock and
death. Pathologic electrocardiography (ECG) was signiﬁcantly more
often found in patients with DOBV infections (Markotic´ et al.,
2002b). Both, Croatian and Slovenian patients, infected with DOBV
had a signiﬁcantly lower number of platelets and higher levels
of creatinine than PUUV-infected patients. All patients had ele-
vated liver transaminases and Slovenian DOBV infected patients
had signiﬁcantly higher alanine aminotransferase (ALT) levels,
while Croatian DOBV infected patients had signiﬁcantly higher total
bilirubin levels (Avsˇicˇ-Zˇupanc et al., 1999; Markotic´ et al., 2002b).
Wide spectrum of clinical symptoms and signs, as well as
clinical laboratory parameters observed among DOBV or PUUV
causing HFRS might be at least in part related to different immune
responses and viral load kinetics. Recent ﬁndings pointed toward
notable differences between PUUV and DOBV infections, in terms
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Table 2
HFRS as multisystemic disease in South-East Europe.
CNS/ocular disorders Blurred vision
Headache
Pathologic electroencephalogram (epileptic
seizure)
Intracerebral bleeding
Endocrine disorders Hypopituitarism
Respiratory disorders Cough
Sneezing
Pathologic lung X-ray (interstitial
inﬂammatory inﬁltrate, pleural effusion,
discoid atelectasis)
Cardiovascular disorders Pathologic electrocardiography (mild disorders
of intraventricular conduction, non-speciﬁc
alteration of the ﬁnal complex, nonspeciﬁc
depolarization disorders, sinus tachycardia in
febrile stage, bradycardia-oliguric stage,
intraatrial conduction disorders, apicarditis)
Hypertension
Hypotension
Shock
Gastrointestinal disorders Abdominal pain
Vomiting
Diarrhea
Melena
Abdominal effusion
Hepatomegaly
Elevated liver transaminases and total
bilirubine
Acute pancreatitis
Renal disorders Oliguria
Anuria
Renal failure
Elevated urea and creatinine
Pathologic renal ultrasonography (renal
edemy, parenchymal stretching, kidneyT. Avsˇicˇ Zˇupanc et al. / Vir
f viral load and antibody and cytokine response dynamics, all of
hich may  be reﬂected in differing disease severities and clini-
al outcomes. Measuring viral RNA in patient samples revealed
hat viremia lasts for longer than previously believed, with DOBV
r PUUV infected patients having viremia lasting on average 30
ays or 16 days, respectively. DOBV infected patients were found
o have a higher viral load than the PUUV infected patients. Both
OBV and PUUV infected patients had IgM at the time of hospital
dmission, but there was a difference in IgG antibody dynamics,
ith only a minority of DOBV infected patients having IgG anti-
odies. However, elevated levels of IL-10, TNF- and IFN- were
etected in peripheral circulation of all HFRS patients regardless
f the causative agent. In DOBV infected patients the decrease in
ytokine secretion level appeared around day 20 post-infection,
hile in PUUV infected patients the change was  earlier (Korva
t al., 2013b). In contrast, some of our unpublished results indicated
hat some cytokine soluble receptors could be increased in DOBV
nfected patients. Previous studies showed increased expression of
oth early and late T-cell activation antigens, e.g. CD25, CD71 and
LADR, memory cells and sCD23, which positively correlated with
iochemical parameters (AST, ALT, urea, a2-globulin) during the
cute phase of HFRS. The phenotypic changes observed, especially
arly and late T-cell activation markers, as well as memory cells,
ould be useful parameters in the evaluation of the HFRS course,
nd prognostic factors of HFRS severity. No signiﬁcant differences
ere found between patients infected with PUUV or with DOBV
Markotic´ et al., 1999).
It is well known today that after HFRS in a certain percentage
f patients chronic squeal could be observed. A 10-year follow-up
tudy in B&H showed that renal function in HFRS patients was in
ormal limits, although after DOBV/infection, glomerular ﬁltration
ate was signiﬁcantly lower than after PUUV infection (Tulumovic
t al., 2010). However, our 16-year follow-up study revealed addi-
ional parameters of renal impairment in previous PUUV infected
atients (A. Markotic´, unpublished results).
.2. HFRS a systemic disease
HFRS is a systemic infectious disease targeting different organs
nd organ systems. Analyzing clinical records of HFRS patients in
he Balkans, we noticed that in a certain percentage of patients
 symptoms and signs related to different organs and organ sys-
ems are found (Table 2). Some central nervous system symptoms,
ike headache, are usual for HFRS, but some other like epilep-
ic seizures accompanied with pathologic electroencephalography
ECG) or intracerebral bleeding have been recorded as well (Avsˇicˇ-
ˇupanc et al., 1999; Cerar et al., 2007; Markotic´ et al., 2002b; Pal
t al., 2005). Endocrine disorders are not detected very often, but
ypopituitarism with atrophic pituitary gland was  reported as a
ate complication of HFRS (Pekic et al., 2005). Respiratory symp-
oms appear frequently and are especially connected to PUUV
nfection. Besides cough and sneezing in some patients, in about
alf of HFRS patients we can ﬁnd pathologic pulmonary X-ray
ndings, such as pneumonitis presented with interstitial inﬂam-
atory inﬁltrates and sometimes pleural effusion (Avsˇicˇ-Zˇupanc
t al., 1999; Markotic´ et al., 2002b). Cardiovascular disorders are
allmarks of HFRS pathophysiology. Transient ECG changes are
ecorded in about 40% of HFRS patients, mostly in the oliguric phase
Markotic´ et al., 2002b; Pal et al., 2005; Puljiz et al., 2005). Although,
e usually do not see ﬁve HFRS phases in our patients, hyperten-
ion could develop at the beginning of the diseases, followed by
ypotension and shock in severe cases (Avsˇicˇ-Zˇupanc et al., 1999;
arkotic´ et al., 2002b). Some gastrointestinal symptoms appear in
ll HFRS patients and can cause difﬁculties in diagnosis at the begin-
ing of HFRS. Strong abdominal pain, followed by gastrointestinal
leeding can direct diagnosis toward some surgical diseases. Liverenlargement, diffuse lesion of the parenchyma,
hypotonia of the canal system)
disorders, like hepatomegaly and elevated liver transaminases and
bilirubin have been frequently diagnosed in HFRS patients. How-
ever, there is a huge gap in our understanding of liver disorders in
HFRS and its possible role in the pathophysiology of disease (Avsˇicˇ-
Zˇupanc et al., 1999; Markotic´ et al., 2002b; Papa et al., 2010). Acute
pancreatitis was observed in DOBV infection as well (Puca et al.,
2012). Another hallmark of HFRS in the Balkans, like in other parts
of the world, is renal disorder. Elevated levels of urea and creati-
nine are helpful in early HFRS diagnosis. Oliguria is common in at
least one third of patients and anuria and acute renal failure require
temporary hemodyalisis (Avsˇicˇ-Zˇupanc et al., 1999; Markotic´ et al.,
2002b). Also, pathologic renal ultrasounds characterized with kid-
ney enlargement, renal edema and hypotonia of the canal system
are observed (Table 2) (Markotic´ et al., 2002b). Recently, we com-
pared different initial clinical symptoms and laboratory ﬁndings
in patients who developed oliguric acute renal failure (ARF) with
those in patients who  did not develop oliguric ARF. We  identiﬁed
the following risk factors for the development of oliguria and anuria
on multivariable analysis: conjunctival hyperaemia or bleeding
(relative risk (RR) 1.84, 95% CI 1.09–3.10; p 0.023), diarrhea (RR 1.45,
95% CI 1.07–1.97; p 0.017), serum sodium of Ł133 mM (RR 2.21, 95%
CI 1.34–3.64; p 0.002), and dipstick protein values of >1.5 g/L (RR
1.59, 95% CI 1.09–2.33; p 0.016), as well as hiking in the forest (RR
1.92, 95% CI 1.13–3.26; p 0.016). Our ﬁndings may  help physicians
in the earlier identiﬁcation of patients with a more severe form of
HFRS caused by PUUV or DOBV (Turcinov et al., 2013).
Due to such diversity of clinical signs and symptoms the list
of differential diagnosis is long: acute renal failure of another
etiology, acute febrile urinary tract infection, tubulointerstitial
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ephritis of other etiology, acute and chronic glomerulonephri-
is, acute abdomen, including appendicitis, hemorrhagic scarlatina,
emolytic uremic syndrome (HUS), thrombocytopenic thrombotic
urpura (TTP), acute respiratory infections, sepsis, other hemor-
hagic fevers (e.g. Congo–Crimean hemorrhagic fever in Bulgaria,
lbania, Kosovo, Greece) (Christova et al., 2013; Markotic´ et al.,
996, 2002b; Sargianou and Papa, 2013). However, leptospirosis is
n the ﬁrst place in differential diagnosis of HFRS in the Balkans.
oth causative agents have the same rodent reservoirs, both are
ndemic in South-East Europe and have almost the same symptoms
nd clinical laboratory ﬁndings at the onset of disease. Patients with
eptospirosis usually have calf pain and higher levels of ALT, AST and
specially total bilirubin (Markotic´ et al., 2002a; Sion et al., 2002).
he phenotypic changes (increased early T-cell activation markers
n HFRS patients), could be useful parameters to distinguish the
wo diseases in the early acute phase (Markotic´ et al., 2011). Dual
nfections should be considered as well with more severe clinical
ictures (Markotic´ et al., 2002a).
In support to our hypothesis that immune status may  be respon-
ible for disease severity is an unusual outbreak recorded in 2002
mong former intravenous drug users in a drug treatment com-
unity Susret, Ivanovac, northeast of Croatia. A man  aged 30 years
eveloped severe HFRS with fulminant systemic hemorrhage and
cute renal failure, and died. Other HFRS patients developed mild
r moderate disease. About 55% of community members were
nfected with either hepatitis B virus or hepatitis C virus, or both.
nterestingly, 82% of the HFRS patients were infected with one or
oth types of hepatitis virus (Medved et al., 2002).
. Treatment
Currently there is no speciﬁc therapy for HFRS. Symptomatic
reatment with careful and balanced liquid and salts replacement is
mportant. Acetylsalicylic acid and non-steroid anti-inﬂammatory
rugs should be avoided. Instead, paracetamol should be used for
ever or pain treatment when necessary. In case of a severe clinical
icture, patients should be managed in a intensive care unit and
emporary haemodialysis in cases of acute renal failure and anuria
ould be required (Markotic´, 1996).
. Prevention
Human behavior plays a critical role in the chance for han-
avirus infections. Epidemiological investigations of risk factors
or human infections revealed that professions related to forestry,
arming, military activities or outdoor activities such as camping
r using summer houses and hiking were identiﬁed as risk factors
Watson et al., 2014). Further risk factors include seeing rodents
nd their excreta, cleaning and working in barns and woodsheds,
leaning basements and gathering ﬁrewood. Thus, prevention of
antavirus infections is based on awareness and personal preven-
ive measures to avoid virus-contaminated dust during work or
eisure time, on proper cleaning and disinfecting areas containing
odent droppings and on continuous rodent control in and around
uman dwellings. In addition, minimizing food available to rodents
round residential areas is known to effectively reduce the rodent
opulation (Kraigher et al., 2012). Some of the Balkan countries had
ublic health institutional guidelines on preventive measures avail-
ble and they communicate preventive measures using a variety of
edia in case of an outbreak.
There is currently no hantavirus vaccine licensed in Europe.esearch in molecular vaccine development is in process with
andidate vaccines under phase I testing, but there are technical,
egulatory and economic problems which need to be solved before
 vaccine would become available (Schmaljohn, 2012). The Balkansearch 187 (2014) 27–33
represent an area with a potential need for hantavirus vaccines,
but due to the co-existence of DOBV and PUUV causing HFRS in the
same region, a two-component vaccine is required (Schmaljohn,
2009).
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